These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4643395)

  • 1. Long-term effects of hydroxyurea in psoriases.
    Dahl MG; Comaish JS
    Br Med J; 1972 Dec; 4(5840):585-7. PubMed ID: 4643395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea: a new antimetabolite in the treatment of psoriasis.
    Rosten M
    Br J Dermatol; 1971 Aug; 85(2):177-81. PubMed ID: 5571034
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined methotrexate and hydroxyurea therapy for psoriasis.
    Sauer GC
    Arch Dermatol; 1973 Mar; 107(3):369-70. PubMed ID: 4692125
    [No Abstract]   [Full Text] [Related]  

  • 4. Psoriasis with hydroxyurea. An 18-month study of 60 patients.
    Moschella SL; Greenwald MA
    Arch Dermatol; 1973 Mar; 107(3):363-8. PubMed ID: 4692124
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver damage due to methotrexate in patients with psoriasis.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
    Gilbert SC; Klintmalm G; Menter A; Silverman A
    Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis following prolonged treatment of psoriasis with methotrexate orally.
    Robeson JA; Spenney J; Hirschowitz BI
    South Med J; 1972 Apr; 65(4):453-6. PubMed ID: 5028402
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxyurea. A new treatment for psoriasis.
    Leavell UW; Yarbro JW
    Arch Dermatol; 1970 Aug; 102(2):144-50. PubMed ID: 4914264
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy of psoriasis.
    McDonald CJ
    Int J Dermatol; 1975 Oct; 14(8):563-74. PubMed ID: 1100544
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate in the treatment of psoriasis at the National Skin Centre, Singapore.
    Lim JT; Tham SN
    Ann Acad Med Singap; 1994 Nov; 23(6):848-51. PubMed ID: 7741497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis caused by methotrexate in the treatment of psoriasis.
    Muller SA; Farrow GM; Martalock DL
    Arch Dermatol; 1969 Nov; 100(5):523-30. PubMed ID: 5350402
    [No Abstract]   [Full Text] [Related]  

  • 16. Megaloblastic anemia in the management of severe psoriasis.
    Woofter JC; Anderson PC
    W V Med J; 1975 Dec; 71(12):352-3. PubMed ID: 1060245
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of methotrexate in psoriasis.
    Roenigk HH; Maibach HI; Weinstein GD
    Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
    O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF
    Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limitations and risks of therapy of psoriasis with amethopterin and hydroxyurea].
    Ottolenghi F; Andreassi L
    G Ital Dermatol Minerva Dermatol; 1971 Sep; 46(9):385-96. PubMed ID: 4255617
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic structure and function in psoriasis before and after treatment with methotrexate.
    Barnardo D; Almeyda J; Baker H; Landells J; Levene G
    Gut; 1971 Oct; 12(10):863. PubMed ID: 5123287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.